As of February 2026 AgomAb Therapeutics has a market cap of ยฃ0.57 Billion. This makes AgomAb Therapeutics the world's 6471th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Feb 10th, 2026 the market cap of AgomAb Therapeutics was reported to be: